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Abstract
Serum and glucocorticoid inducible kinase 1 (SGK1) plays a pivotal role in early angiogenesis during embryonic
development. In this study, we sought to define the SGK1 downstream signalling pathways in the adult heart and to
elucidate their role in cardiac neo-angiogenesis and wound healing after myocardial ischemia. To this end, we
employed a viable SGK1 knockout mouse model generated in a 129/SvJ background. Ablation of SGK1 in these
mice caused a significant decrease in phosphorylation of SGK1 target protein NDRG1, which correlated with
alterations in NF-κB signalling and expression of its downstream target protein, VEGF-A. Disruption of these
signalling pathways was accompanied by smaller heart and body size. Moreover, the lack of SGK1 led to defective
endothelial cell (ECs) migration and tube formation in vitro, and increased scarring with decreased angiogenesis in
vivo after myocardial infarct. This study underscores the importance of SGK1 signalling in cardiac neo-angiogenesis
and wound healing after an ischemic insult in vivo.
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Introduction
Neo-angiogenesis, the process of new blood vessel
formation from the pre-existing network of capillaries, is a
response to many physiological and pathological conditions
such as myocardial ischemia, diabetes and cancer [1,2]. In the
heart, activation of neo-angiogenesis around the ischemic area
helps to supply oxygen and nutrients thereby decreasing cell
death and scar formation [1,2]. During embryonic development,
serum and glucocorticoid inducible kinase 1 (SGK1) is reported
to be an important player in early angiogenesis [3]. SGK1 is a
serine-threonine protein kinase first cloned from rat mammary
tumours in response to glucocorticoid stimulation [4]. SGK1
belongs to the AGC kinase subfamily, acting downstream of
insulin and growth signalling pathways in response to
phosphorylation by PIP3-dependent protein kinase-1 (PDK1)
[5]. Two additional distinct SGK isoforms have been identified
(SGK2 and SGK3). All SGK isoforms share similar target
specificities with other AGC family members such as Akt
(PKB), RSK, and S6K [6].
N-Myc downstream regulated gene-1 (NDRG1, Cap 43,
Drg1) is the specific physiological substrate for SGK1 [7].
NDRG1 expression is regulated by oncogenes (N-myc and C-
myc) and tumour suppressors (p53, VHL, and PTEN) [8]. Over-
expression of NDRG1 has been shown to suppress tumour
growth through modification of angiogenesis [9]. Both over-
expression and phosphorylation of NDRG1 by SGK1 have
been reported to inhibit the nuclear factor kappa B (NF-κB)
pathway and decrease expression of angiogenic genes such
as CXC chemokines and vascular endothelial growth factor-A
(VEGF-A) [9,10].
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In previous analyses, we found that SGK1-/- mice, generated
as 129/SvJ background are viable with no significant cardiac
phenotype [11]. Nevertheless, when backcrossed for more than
five generations in C57BL/6 background they showed
embryonic lethality due to an early cardiovascular defect at
E10.5-E11.5 [3]. Based on these data, we investigated the role
of SGK1 and NDRG1 phosphorylation in cardiac neo-
angiogenesis and wound healing in adult SGK1 null mice on a
129/SvJ mouse background. We show that inactivation of
SGK1 caused a dramatic decrease in NDRG1 phosphorylation
in the heart and endothelial cells (ECs). NDRG1 modulation
was associated with degradation of NF-κB inhibitory proteins
and increased in VEGF-A protein expression. This disrupted
signalling resulted in defective migratory and in vitro tube
formation capacity of SGK1-/- ECs compared to wild-type (WT)
ECs. Importantly, in vivo analyses showed that SGK1 deletion
worsened scar formation a month after coronary artery ligation
due to lower density of vessels per cardiomyocyte around the
scar area compared to WT mice. Our results elucidate the role
of SGK1 signalling in the regulation of angiogenesis and wound
healing in the adult heart, an effect involving phosphorylation of
its downstream substrate NDRG1.
Materials and Methods
Mice
All animal studies and breeding protocols were performed in
compliance with international (Directive 2010/63/EU of the
European Parliament) and national (UK Home Office, Act
1986) regulations. Imperial College board Committee granted
internal ethical approval. All animals were examined daily for
development of any adverse signs and symptoms indicating
pain, distress or discomfort. Any animal giving cause for
concern was weighed and monitored and if there was body
weight loss of more than 20% and/or significantly laboured
breathing as well as the following clinical signs: piloerection,
hunched posture, reduced mobility, pallor, ocular or nasal
discharge, diarrhoea was humanely culled as described below.
In all experimental procedures mice were anaesthetised with
inhaled Isoflurane (1.5-2.5%) and 1.5 ml/min O2. Adequacy of
anaesthesia was monitored by foot pinch before incision. For
tissue extraction and primary cell isolation, mice were
euthanized by cervical dislocation after being anesthetised with
4% Isoflurane (National Veterinary Services, NVS, UK). After
surgery, animals were allowed to recover with free access to
food and water. Injection of analgesia (e.g. buprenorphine) was
performed as required post-operatively. SGK1-/- mice were
genotyped as previously described [11]. Male mice were used
for physiological studies and isolation of cardiomyocytes and
female mice were used for isolation of ECs.
Materials
Antibodies: pan SGK (≠3272), SGK2 (≠5595), SGK3
(≠8156), p-NDRG1-Thr346 (≠5482), NF-κB2/p100 (≠4882),
GAPDH (≠2118) were purchased from Cell Signalling; total
NDRG1 from university of Dundee (DSTT); VEGF-A (≠sc-507),
and inhibitor of kappa-B alpha (IκBα) (≠sc-56710) antibody
from Santacruz; Isolectin beta-4 (ILB4) (≠L2140) and Wheat-
germ agglutinin (WGA) (≠L4895) from Sigma; Matrigel from BD
Biosciences (≠734-0269); Proliferation kit from Roche (≠11 810
740 001); CytoSelect migration assay (≠CBA-106) from Cell
Biolab and di-8-ANEPPS from Molecular Probes.
Echocardiography
2-3 month old WT and SGK1-/- mice were analysed under
anaesthesia (2.5% Isoflurane, 1.5 ml/min O2). Short-axis view
trans-thoracic echocardiography (ECHO) was performed on
shaved mice at the height of the papillary muscles. The
operator was blinded at the time of measurement to genotype
of each mouse analysed. Ejection fraction (%EF) was
determined in 2D and M-mode, fractional shortening (%FS)
was measured in M-mode by a Sonos 5500 (Philips) equipped
with a 15MHz transducer.
Coronary artery ligation
Left coronary artery ligation was performed on 3 month old
mice as previously described [12]. In brief, mice were
anaesthetized with 1.5% Isoflurane and the chest cavity was
opened in the left fourth intercostal space. The heart was
exposed and the left anterior descending coronary artery (LAD)
was ligated with an 8.0 non-absorbable suture (Ethicon) below
the left atrium to produce an infarct size of about 40%. Mice
were sacrificed one month after ligation and samples were
collected for immunohistochemistry, protein and RNA analysis.
Immunohistological analysis
Hearts were harvested, washed in PBS and fixed in 4%
paraformaldehyde. The fixed heart samples were then
embedded in paraffin and 5 µm microtome sections were used
for different staining after being deparaffinised and boiled for 10
minutes in 10 mM sodium citrate (pH=6). Microvessels were
stained with endothelial cell marker ILB4 (Biotinylated) at a 100
fold dilution and cardiomyocytes were stained with the marker
Wheat-germ agglutinin (WGA), FITC conjugated, at a
concentration of 5µg/ml. Microvessels and cardiomyocytes
were counted in 10 defined microscope fields. To quantify the
scar area after coronary artery ligation, heart sections were
stained with picro-sirius red for collagen deposition. Three
different sections at the start, mid and the end of scar were
used for staining and the percentage of scar size was reported
as the mean value of epicardial and endocardial scar in each
section using NIS-element AR3.0 software.
Immunoblotting
Western blot analysis performed on tissue and/or cell
extracts as previously described [13]. In brief 40-50µg protein
samples were loaded to SDS-gel followed by electrotransfer to
a nitrocellulose membrane. Primary antibodies were applied at
a 1000 fold dilution for commercial antibodies and of 0.1 µg/ml
concentration for Total NDRG1 (Dundee) in TBS/Tween
overnight at 4°C. Protein detection was performed using
horseradish peroxidase conjugated secondary antibodies and
the enhanced chemiluminescence reagent.
Bands were quantified with ImageJ, a Java-based image
analysis package widely used for measurement of density
SGK1 in Cardiac Angiogenesis
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profiles, peak heights as well as peak intensity (average OD of
the band, INT) or volume (average OD of the band times its
area, INT*mm2) of the band of the expected molecular weight.
Briefly, after scanning the western blot films, the images were
saved as jpg format. After opening the image in the Image J
program, the area around each band was specified by
rectangular selection in the program tools. The program then
plots the same rectangular around all the other bands and
quantifies the intensity of each band. The intensity of each
band was then normalised with the intensity of corresponding
loading controls.
Real Time PCR
Total RNA was extracted and quantitative real-time reverse-
transcribed polymerase chain reaction was performed as
described previously [14] with off-the-shelf Taqman probes
(Applied Biosystems). Analysis was performed with the ΔΔCt
method with an 18S probe for normalization.
Primary cell preparation
Cardiomyocytes were isolated from 2-3 month old male mice
after standard enzymatic digestion as previously described
[15]. Cardiomyocytes were then stained with the membrane
binding dye di-8-ANEPPS (10µM) for 10 minutes in the dark.
Confocal image stacks were obtained using the Zeiss LSM 510
microscope with 40x objective lens using Argon 488 laser. The
images were analysed to calculate cell volume as previously
described [16].
ECs were isolated from 2-3 month old mice. After euthanasia
hearts were excised and minced in cold PBS. Single cell
isolation was achieved after digestion of hearts in collagenase
IV (Roche) for one hour at 37°C. Cell debris was discarded
through a cell strainer (100µm) and cardiomyocytes were
removed after first centrifugation at 20g. The remaining cells
were washed by centrifugation at 300g several times with PBS/
EDTA/BSA buffer (PEB buffer) containing phosphate buffer
saline (PBS) 1X, pH 7.2, 0.5% bovine serum albumin (BSA)
and 2 mM EDTA. Cells were then labelled with EC marker
CD146 (Miltenyi Biotec ≠130-092-007) and selected through
magnetic cell separation (MACS) columns as recommended by
manufacture’s experimental procedure (Milteny Biotec, Inc.).
ECs were cultured in DMEM supplemented with 10% FCS,
endothelial cell growth factors (ECGS) (Sigma) and heparin in
1% fibronectin pre-coated culture dishes for 1 week.
EC proliferation analysis
ECs were cultured on chamber slides to reach 50%
confluence. Proliferation of ECs was measured using In Situ
Cell proliferation kit (Roche) according to the manufacturer. In
brief ECs were incubated with a thymidine analogue, 5-
bromo-2`-deoxyuridine (BrdU) at the concentration of 10 µM for
24h. At the end of the incubation time, cells were fixed with a
mixture of ethanol/glycine (50 mM, pH 2.0), washed with PBS
and stained with anti-BrdU-FLUOS antibody for 45 minutes
followed by DAPI staining for 5 minutes. The number of BrdU
positive cells was evaluated by Zeiss fluorescent microscopy
and normalized by the total number of cell nuclei stained with
DAPI.
EC migration analysis
Primary ECs from mice heart were serum starved for 12h
and subsequently seeded at 1-2x104 cells per well in a serum-
free media into the upper chamber of CytoSelect™ 96-well cell
migration (Cell Biolabs) covering the lower chamber with a
polycarbonate membrane with a diameter of 8 µm. Cells were
allowed to migrate toward 10% FCS for 24h. The migratory
cells on the bottom of the membrane were then detached and
quantified using CyQuant GR fluorescent dye at 480nm/520
nm wavelength using fluorescent plate reader as described by
manufacturer (Cell Biolab).
EC tube formation analysis
1-2x104 primary ECs were seeded on Martigel (BD
Biosciences) coated 12 well plate culture dishes. Tube
formation was visualized at 10X magnification with Zeiss light
microscopy after 7 and 24h. In a subset of experiments, VEGF-
A was neutralized by adding VEGF-A antibody (2ug/ml) and
control rabbit IgG to the media as previously described [17].
Tube formation was quantified by tracing along the tubes using
NeuronJ software (an ImageJ plugin). The number of traces
per 8 bit jpeg images was quantified from 10 different culture
dishes. The significance of the results was assessed using a
Student-t test.
Kinexus Proteomic Analysis
Three WT and SGK1-/- hearts were lysed in non-denaturing
buffer purchased from Kinexus Bioinformatics Corporation
(Vancouver, Canada). Samples were delivered to Kinexus in
dry ice and subsequently labelled with fluorescent dye.
Labelled samples were run on a KinexTM 850-KAM antibody
microarray chip containing 850 different antibodies. Detected
fluorescent samples were quantified and the differences
between WT and KO analysed as Z-ratio (KO/WT fluorescent
intensity).
Adenovirus infection
Three months old WT and KO mice were used to extract
endothelial cells as described above. Isolated cells were
maintained in DMEM supplemented with 10% FCS, endothelial
cell growth factors (ECGS) (Sigma) and heparin in 1%
fibronectin pre-coated culture dishes for 1 week. Cells were
then trypsinized and plated 50-60% confluency in EC media for
12 hours, prior infection with an adenovirus expressing the
constitutively active form of SGK1 and a control adenovirus
expressing beta-Galactosidase (βGal) [18]. Cells were infected
for 12 hours in DMEM containing 10% FBS followed by plating
on matrigel coated dishes as described above. Tube formation
was assessed 7 hours after plating.
Statistical analysis
GraphPad Prism (version 5) was used to perform statistical
analysis. Student t -test analysis was performed for normally
distributed data. ANOVA was used as indicated in Figure
legends. Results were presented as the average± SE. *p<0.05,
**p<0.01, ***p<0.001
SGK1 in Cardiac Angiogenesis
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Results
SGK1-/- mice display a cardiac phenotype
Generation of SGK1-/- mice has been described previously
[11]. In brief, exons 4-11, which encode the SGK1 kinase
domain, were constitutively deleted in the germ line using Cre-
lox technology. The mice were fertile and showed no significant
phenotype apart from their smaller body weight and heart
weight (Table 1). Echocardiography analyses revealed that
cardiac systolic and diastolic functions defined by %EF, %FS
and E/A ratio respectively were comparable between WT and
SGK1-/- mice. However, a significantly slower heart rate was
observed in SGK1-/- mice (Table 1).
Decreased heart weight observed in SGK1-/- was
accompanied by reduced cardiomyocyte size evaluated by
cross-sectional area in WGA stained heart sections (Figure 1A)
and by cell volume measured in isolated adult cardiomyocytes
(Figure 1B).
Reduced NDRG1 phosphorylation in SGK1-/- hearts
To investigate the effectiveness of SGK1 deletion, heart
samples from WT and SGK1-/- mice were analysed for SGK
protein expression by Western blotting. As shown in Figure 2A,
the pan SGK antibody recognizes different SGK isoforms.
However, the expression of the middle band at 54 KDa
corresponding to SGK1 isoform was abolished in SGK1-/-
mice. To further investigate the ablation of SGK1 in these
animals, the phosphorylation state of NDRG1, a downstream
target of SGK1 was examined. NDRG1 is specifically
phosphorylated by SGK1 at residue threonine-346 [7].
Correspondingly, Western blot analysis of SGK1-/- whole heart
samples showed a significant decrease in NDRG-1
phosphorylation at threonine-346 (Figure 2A). Decreased
Table 1. Cardiac phenotype of SGK1-/- mice.
 WT SGK1-/-
Morphologic: (n=8) (n=7)
HW (mg) 190±3 120±5*
HW/BW 5.5±0.1 5.1±0.2
BW (g) 34±1 23.4±0.9*
Echocardiographic: (n=8) (n=7)
LVEDD (mm) 4.33±0.0 4.17±0.0
LVESD (mm) 2.91±0.1 2.64±0.1
EF% 67±3 72±2
FS% 33±2 36±1.6
HR 415±2 319±13**
E/A 1.5±0.2 1.7±0.14
Mice were weighed at 8 weeks and dissected wet heart weight measured. 2-3
month old male mice were used for functional analysis of the heart by measuring
the percentage of ejection fraction (%EF) and fractional shortening (%FS). n,
number of mice, BW, body weight, HW, heart weight; HW/BW, ratio of HW to BW;
LVEDD, left ventricular end diastolic diameter; LVESD, left ventricular end systolic
diameter; HR, heart rate. E/A, maximal speed of early to late mitral filling ratio.
Student t-test has been used to calculate significance and * p<0.05; **p<0.01.
doi: 10.1371/journal.pone.0080268.t001
NDRG-1 phosphorylation was also observed in primary ECs,
adult cardiomyocytes and fibroblasts isolated from SGK1-/-
mice (Figure 2B and 2C). Importantly, the expression levels of
the other isoforms SGK2 and SGK3 in the heart assessed by
western blot did not show any significant difference between
WT and SGK1-/- mice, ruling out any compensatory
modifications in the level of these isoforms (Figure S1).
Modification of NF-κB pathway in SGK1-/- hearts
To investigate NF-κB signalling, which is downstream of the
SGK1/NDRG1 pathway, Western blot analysis was performed
on WT and SGK1-/- heart samples for two well-known
inhibitory components of NF-κB pathways: IκBα in the
canonical and NF-κB2/p100 in the non-canonical pathway [19].
The expression level of VEGF-A was also assessed by
Western blot as a transcriptional target of NF-κB [20]. As
shown in Figures 3A and 3B, expression of both inhibitory
proteins, IκBα and NF-κB2/p100, was downregulated in
SGK1-/- heart samples. Decreases in these inhibitory
components were accompanied by a significant increase in all
VEGF-A isoforms (25, 20 and 15 KDa) in SGK1-/- heart
samples (Figure 3C). Furthermore, extracts from cardiac cell
types showed that endothelial cells are the main producers of
VEGF in SGK1 KO hearts compared to cardiomyocytes,
secreting similar levels of this factor (Figure S2A and S2B).
Proteomic profile of SGK1-/- hearts
To investigate whether deletion of SGK1 was involved in
regulating other downstream targets, we performed proteomic
analyses by assessing the expression and phosphrylation
profile of 850 different proteins using a Kinexus antibody
microchip array (Figure S3). Our data showed that depletion of
SGK1 is associated with differential regulation of proteins
implicated in cell cycle initiation or progression such as Aurora
A (1.5+/-0.41 fold induction compared to WT heart) [21], PAC1,
regulator of mitotic and apoptotic signalling (3.6+/-1.9 fold
induction compared to WT) [22,23] and CDK7 activator of
transcription [24] (-4.7+/-2.7 fold reduction compared to WT).
Interestingly, Btk, known to activate NFkB [25,26], is induced a
1.4+/-0.3 fold in SGK1-/- hearts compared to WT, further
corroborating the data presented in this manuscript.
Defective tube formation in SGK1-/- ECs
The role of SGK1 in EC tube formation was examined by
culturing primary ECs isolated from WT and SGK1-/- mice on
Matrigel-coated culture dishes. As shown in Figure 4A, ECs
isolated from SGK1-/- mice formed fewer tube networks after 7
and 24 h, compared to WT cells. Importantly, re-expression of
SGK1 by infection of ECs with an adenovirus encoding the
constitutively active form of SGK1 (Figure S4A and S4C) re-
established tube networks compared to KO ECs infected with
control virus expressing βGal (Figure S4B).
To investigate whether this phenotype was due to a defect in
proliferative capacity of SGK1-/- ECs, we incubated the ECs
with a thymidine analogue, 5-bromo-2`-deoxyuridine (BrdU) for
24h. Figure 4B presents the ratio of BrdU incorporated cells per
total amount of cells stained with DAPI. No significant
differences were observed between WT and SGK1-/- ECs,
SGK1 in Cardiac Angiogenesis
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excluding altered proliferative capacity as an explanation for
lower tube formation. Assessment of ECs migratory capacity
showed a significantly higher migration level in ECs isolated
from WT than from SGK1-/- hearts (Figure 4C), indicating that
SGK1 signalling supports ECs migration. We further analysed
the effect of VEGF-A on ECs tube formation by neutralizing
VEGF-A in the media. Our results demonstrated that blocking
VEGF-A partially improved SGK1-/- ECs capacity to form tubes
(Figure S2C). To analyse whether ECs contribute to the
signalling observed in the hearts, expression of NFκB inhibitory
proteins was measured by western blot analysis. In Figure 4D,
it is shown that IκBα expression in the canonical pathway is
downregulated, although no differences were found in NF-κB2/
p100 expression levels (communication from the authors).
These data suggest that the canonical pathway of NFκB is in
part regulating EC function.
Modulation of SGK1 signalling in SGK1-/- hearts in
response to myocardial ischemia
To investigate the impact of defective SGK1 activity on
cardiac recovery after ischemic insult, mice were subjected to
left anterior descending coronary artery ligation (LAD).
Assessment of SGK1 downstream pathways was performed by
western blot analysis one month after coronary artery ligation
to explore whether ischemic insult modulated the signalling
observed in physiological conditions (Figure 5). NDRG1
phosphorylation decreased in SGK1-/-hearts a month after
infarction (Figure 5A). This was accompanied by decreases in
IκBα and NFκB2/p100 protein expression (Figure 5B) and
increases in expression of all VEGF-A isoforms (Figure 5C).
Thus, in pathological conditions, SGK1 ablation modulates
similarly the signalling pathways observed in physiological
conditions.
Figure 1.  Lack of SGK1 correlated with reduced cardiomyocyte size.  (A) Cross sectional area in heart sections from WT and
SGK1-/- mice. Area was measured in ≥10 distinct microscope field for each slide. Four hearts were analysed for each slide in both
WT and SGK1-/- mice. Scale bar represents 50 µm. (B) Confocal images of isolated adult cardiomyocytes form WT and SGK1-/-
mice The data represent the average of three independent experiments and are reported as Mean ± SE. Cell volume was measured
using a custom-written macro in ImageJ. Scale bars represent 5µm. Statistical analysis has been performed as described in
Materials and Methods using Student t-test; *** indicates p<0.001.
doi: 10.1371/journal.pone.0080268.g001
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Lack of SGK1 increases cardiac fibrosis and correlates
with defective capillary formation after coronary artery
ligation
Cardiac fibrosis was evaluated one month after myocardial
ischemia in SGK1-/- and WT mice by histochemical analysis
and collagen3a (Col3a) gene expression (Figure 6 A and B).
Specifically, the expression level of Col3a was significantly
increased after myocardial ischemia and was further
upregulated in SGK1-/- mice (Figure 6A). Consistent with this
genetic profile, immunohistochemical analysis of heart sections
using the collagen marker Sirius red showed an increased
collagen deposition and scar size in SGK1-/- mice (Figure 6B).
To investigate the potential impact of defective ECs on
cardiac recovery and neo-angiogenesis after ischemic insult,
mice were analysed for vessel density. Isolectin B4 did not
stain large vessels (Figure S5A) and was used to mark the
microvasculature of WT and SGK1-/- hearts (Figure S5A and
S5B). Vessel density was measured in heart sections before
and after myocardial infarct (Figure 7 A and B) and was
reported as number of ILB4-positive vessels per cardiomyocyte
(Figure 7 C) and per mm2 (Figure 7D). No significant difference
was observed between WT and SGK1-/- capillary density
before myocardial ischemia (Figure 7A, C and D), however,
one month after LAD the amount of capillary per cardiomyocyte
and capillary per mm2 around the scar area was significantly
lower in SGK1-/- hearts (Figure 7B, C and D). Measurements
of cardiomyocyte cross-sectional area (Figure 7E) showed no
significant differences between WT and SGK1-/-
cardiomyocytes 1 month after myocardial infarct induction. The
data suggests that decreased vessel formation may lead to
Figure 2.  Downregulation of NDRG1 phosphorylation in SGK1-/- hearts.  Western blot analysis of SGK, phospho-NDRG1 and
total NDRG1 in the heart (A), primary endothelial cells (ECs), adult cardiomyocytes (CMC) and fibroblasts (Fibro) from WT and
SGK1-/- mice (B). Quantification of band intensities was performed using ImageJ. The number of hearts analysed was ≥4 in each
group (C). Significance has been measured by Student t-test has described in Materials and Methods and *** indicates p<0.001, **
p<0.01 and * p<0.05. The data are reported as Mean ± SE.
doi: 10.1371/journal.pone.0080268.g002
SGK1 in Cardiac Angiogenesis
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worsening of cardiomyocyte mechanical stress or to increased
cell death at specific time points after infarction.
Discussion
The present study highlights a novel and pivotal role for
SGK1 in adult cardiac repair after ischemic insult through
promotion of neo-angiogenesis around the scar area. Analysis
of the intracellular signalling pathways involved in SGK1 action
revealed impaired NDRG1 phosphorylation in the heart, as well
as in primary ECs, cardiomyocytes and fibroblasts of SGK1-/-
mice. NDRG1 has been described as an important player in
angiogenesis in different cell systems [27], although its role in
cardiac tissue has not been explored in any detail. Indeed, both
over-expression and phosphorylation of NDRG1 modified
angiogenic gene expression in pancreatic cancer cells through
down-regulation of the NF-κB pathway [9,10].
Here we demonstrated that decreased NDRG1
phosphorylation in SGK1-/- hearts was accompanied by down
regulation of two NF-κB inhibitory components: IκBα and NF-
κB2/p100 proteins. The NF-κB family consists of five members:
NF-κB1 (p105/p50), NF-κB2 (p100/p52), RelA (p65), RelB and
c-Rel [19]. In most cell types, the NF-κB complex is retained in
the cytoplasm by inhibitors of κB proteins (IκBs). The C-
terminal part of NFkB2/p100 also functions as an inhibitor,
retaining the NF-κB complex in the cytoplasm [19]. IκBα and
NF-κB2/p100 degradation leads to release of NF-κB DNA-
binding proteins (p50 and p52) to the nucleus and results in
transcription of its target genes [19]. To corroborate our data,
proteomic analysis showed upregulation of the NF-κB activator
Btk [25,26] in SGK1-/- hearts. These results indicate elevated
Figure 3.  Modulation of NF-κB pathway and VEGF-A expression by SGK1.  Western blot analysis of IκBα (A), NF-κB2/p100 (B)
and VEGF-A (C) in WT and SGK1-/- hearts. GAPDH and α-Tubulin were used as loading controls. Quantification of band intensities
for each represented blot was performed using ImageJ. The number of hearts analysed was ≥4 in each group and statistical
analysis is performed by Student t-test. ** Indicates p<0.01, *** p<0.001. The data are reported as Mean ± SE.
doi: 10.1371/journal.pone.0080268.g003
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NF-κB pathway activity in the heart in response to SGK1
ablation.
Downregulation of both IκBα and NF-κB2/p100 in SGK1-/-
hearts was accompanied by higher levels of VEGF-A, an NF-
κB target protein in both physiological and pathological
conditions.
VEGF-A is a key regulatory component of physiological and
pathological angiogenesis [28]. Notably, both under- and over-
expression of VEGF-A disrupt normal development and vessel
formation: deletion of VEGF-A caused embryonic lethality at
day E9.5 [29], whereas overexpression of VEGF-A up to 2-3
fold resulted in severe cardiac development abnormality and
embryonic lethality at day E12.5-E14 [30]. Mutant embryos
over-expressing VEGF-A displayed cardiac malformation and
aberrant coronary organization [30]. Similarly, in another study
performed in quail embryos, injection of VEGF-A at day E4.5
caused cardiovascular malformation, enlarged heart and thin-
walled myocardium [31]. Higher VEGF-A mRNA expression
was also detected in SGK1-/- embryos at day E9.5 in the
C57BL/6 mice background, which may in part explain their
growth retardation, angiogenesis defect and embryonic lethality
at day E10.5-E11.5 [3]. Accordingly, the smaller size of adult
SGK1-/- mice in a 129/SvJ background can also be a result of
higher VEGF-A protein level. Nevertheless, as SGK1 is a target
of growth factor signalling pathways, the smaller phenotype
could be a direct result of disrupted growth signalling in these
mice. Indeed, we found that the phosphorylation level of
ribosomal protein S6, implicated in protein synthesis signalling,
was lowered in SGK1-/- mice (personal communication from
the authors).
Figure 4.  SGK1 affects EC phenotype.  Primary ECs from WT and SGK1-/- hearts were assessed for tube formation capacity
after culture on Matrigel for 7 and 24h. Tube ramification was quantified using Neuron J software. Scale bars represent 100 µm (A).
Proliferation capacity of ECs measured 24h after incubation with BrdU (B). Endothelial cell migration capacity was measured using
CytoSelect cell migration assay (C). NFkB signalling was measured by analysing the expression levels of the inhibitory protein IkBα.
Blots were normalized for GAPDH. Two representative experiments are shown. Four hearts were used in both WT and SGK1-/-
mice and statistical analysis has been performed by Student t-test as described in Materials and Methods. Ns indicates no
significant; * p<0.05, ***p<0.001. The data are reported as Mean ± SE.
doi: 10.1371/journal.pone.0080268.g004
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ECs are central players in angiogenesis and are targeted by
VEGF-A. Primary ECs isolated from SGK1-/- hearts showed
defective cell migration and failed to form organized networks
when cultured on Matrigel. Importantly, re-expression of SGK1
by infection of an adenovirus encoding CA-SGK1 rescued
formation of tube networks. Perturbation in VEGF-A signalling
may explain the impaired behaviour of SGK1-/- ECs. Indeed,
neutralizing VEGF-A in the media partially improved SGK1-/-
EC tube formation capacity (Figure S2C) further implying a role
for VEGF-A in this process. Although VEGF-A is a major player
in angiogenesis, other signalling may contribute in synergy to
enhance tissue revascularization. Angiogenesis occurs in
several well characterized stages including degradation of
vessel basement membrane, liberation, proliferation and
migration of ECs to make appropriate connections [2], a defect
in any of these steps may result in impaired tube formation and
angiogenesis. Previous studies suggested a role for SGK1 and
NDRG1 in cell migration through modification of adhesion
molecules such as Vinculin and E-Cadherin [32], which may
account for the lower capacity of endothelial cell migration in
SGK1-/- mice leading to defective tube formation.
Defective ECs impaired also cardiac remodelling and neo-
angiogenesis in vivo, evident one month after coronary artery
ligation. At this time, expression levels of fibrotic marker Col3a
were significantly higher in SGK1-/- hearts, correlating with
increased scar size and indicating an increase in the fibrotic
response. Furthermore, the decrease in microvessel density
around the scar area in SGK1-/- hearts clearly demonstrates a
beneficial role for SGK1 in neo-angiogenesis and wound
healing after myocardial ischemia.
It is important to emphasise that other pathological models
may lead to different outcome regarding the role of SGK1 in
fibrosis and cardiac function. Some studies showed a
profibrotic effect of SGK1 in response to mineralocorticoid
Figure 5.  Disruption of SGK1 downstream signalling after coronary artery ligation.  Western blot analysis of NDRG1 (A),
IκBα, NF-κB2/p100 (B) and VEGF-A (C) of WT and SGK1-/- hearts after LAD. GAPDH and α-Tubulin were used as loading controls.
Quantification of band intensities was performed using ImageJ. The number of hearts analysed was ≥4 in each group. Significance
is calculated by Student t-test and * p<0.05, ** p<0.01, ***p<0.001. The data are reported as Mean ± SE.
doi: 10.1371/journal.pone.0080268.g005
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deoxy-corticosterone acetate (DOCA) [33] and angiotensin-II in
vivo [34]. Mineralocorticoids (DOCA) and angiotensin-II are
known as potent inducers of high blood pressure leading to
cardiac remodelling and hypertrophy [35,36]. The higher level
of cardiac fibrosis in response to DOCA or angiotensin-II may
appear to contradict the increased level of Col3a gene
expression and scar formation in the absence of SGK1 after
cardiac infarct. However, the cross-talk between SGK1 and the
downstream signalling pathways activated in myocardial
ischemia and hypertension, respectively, likely lead to
disparate outcomes.
In summary, SGK1 is an important player in angiogenic
processes of the heart after injury. Our analysis of
perturbations in relevant downstream signalling pathways in its
Figure 6.  Effect of SGK1 ablation on cardiac collagen deposition after LAD injury.  (A) Gene expression analysis of Col3a in
WT and SGK1-/- heart one month after LAD. One-way ANOVA has been used to analyse significance among groups. * Indicates
p<0.05 and n was ≥4 in each group. (B) Histological analysis of LAD operated hearts from WT and SGK1-/- mice one month after
operation. Hearts were stained for the collagen marker, picro-sirius red. Epicardial and endocardial scar size was quantified in 3
different hearts in both WT and SGK1-/- and the mean value is the results of 10 distinct microscope field analysed in each group.
Scale bars represent 1mm. Student t-test has been used to calculate p-value and * indicates p<0.05 (B). The data are reported as
Mean ± SE.
doi: 10.1371/journal.pone.0080268.g006
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absence reveals new roles for both NDRG1 and NF-κB in
cardiac pathology representing potential therapeutical and
pharmacological targets in cardiac repair and regeneration
studies.
Conclusion
Our collective findings establish a link between SGK1 and
cardiac neo-angiogenesis, shedding new light on the signalling
pathways implicated in physiologic and pathologic vessel
formation.
Supporting Information
Figure S1.  SGK2 and SGK3 protein expression in the WT
and SGK1-/- hearts. Western blot analysis of SGK2 and SGK3
protein expression in heart extracts from WT and SGK1-/-
mice. GAPDH was used as loading control. Quantification of
band intensities was performed using imageJ. N=4 in each
group. Student t-test showed no significant (ns) differences
between WT and SGK1-/-. The data are reported as Mean ±
SE.
(TIF)
Figure S2.  VEGF expression in cardiac cells and tube
formation analysis of ECs from WT and SGK1-/- hearts in
Figure 7.  Reduced vessel density around the scar in SGK1-/- hearts.  Microvessel density was measured in sham operated (A)
and in LAD hearts (B). Microvessels were stained with biotinylated isolectin beta 4 (ILB4) and cardiomyocytes with WGA. Scale bars
represent 50 µm in sham operated and 20 µm in LAD. The ratio of small vessels per cardiomyocytes (C) and per mm2 (D) is
reported in the graphs. The number of hearts analysed was ≥4 in each group. One-way ANOVA was used to analyse significance
among groups. (E) Measurements of cross-sectional area (CSA) 1 month after infarction in WT and KO mice. The number of hearts
analysed was ≥4 in each group and ten distinct microscope fields for each slide were analysed. Ns, non-significant. ** Indicates
p<0.01, *** p<0.001 and ns, non-significant. The data are reported as Mean ± SE.
doi: 10.1371/journal.pone.0080268.g007
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response to neutralizing VEGF-A. Quantification by Image J
(see Material and Methods) of western blot analysis for the
expression of VEGF-A proteins 20 and 25 in primary
endothelial cells (A) and cardiomyocytes (B). GAPDH was
used as loading control. The number of hearts used was ≥3 in
each group. The data are reported as Mean ± SE. (C) Primary
ECs from WT and SGK1-/- hearts were assessed for tube
formation capacity in response to VEGF-A neutralizing
antibody (2µg/ml). IgG was used as negative control. ECs were
analysed for tube formation after 7h incubation with or without
VEGF-A or IgG.
(TIF)
Figure S3.  Proteomic profile in SGK1-/- and WT hearts.
Three hearts from WT and SGK1-/- mice were lysed and
proteins extracted in non-denaturing conditions by using lysis
buffer from Kinexus. Fluorescent-labelled proteins were
processed by Kinexus onto a KinexTM 850 antibody microarray
chip. Fluorescent emission upon protein-antibody binding was
detected and measured as Z-ratio (emission amount in
SGK1-/- over WT). Expression and/or phosphorylation levels of
different proteins were downregulated (negative values) or
upregulated (positive values). Btk, regulator of NFkB activity,
was upregulated in KO hearts confirming our western blot
analyses.
(TIF)
Figure S4.  Re-expression of SGK1 rescued tube network
formation in KO ECs. ECs from SGK1-/- hearts were isolated
and infected with an adenovirus expressing the constitutive
active form of SGK1 (Ad-SGK1 CA-GFP) and with a control
adenovirus expressing beta-galactosidase (βGal; Ad βGal-
GFP). Both viruses co-expressed green fluorescent protein
(GFP), as shown in panels (A) 12 hours after viral infection.
Infected SGK1-/- ECs formed tube networks 7 hours after
plating in matrigel, conversely to ECs infected with control virus
(B). Total cell extracts from Ad-SGK1 CA-GFP and Ad βGal-
GFP infected ECs were analysed for SGK1 expression. Blots
were normalized with alpha-tubulin. Arrow indicates SGK1
expression in KO ECs infected with Ad-SGK1 CA-GFP or
control virus (C). The reported data have been assessed in two
independent experiments. In each independent experiment,
three separate analyses were performed.
(TIF)
Figure S5.  Isolectin beta 4 staining of vessels.
Microvessels were stained in WT (A) and SGK1-/- hearts (B)
with biotinylated isolectin beta 4 (ILB4). Nuclei were visualized
with DAPI staining. Scale bars represent 50µm and arrows
point to small vessels.
(TIF)
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